Cellebrite DI (CLBT) Stock Price

Cellebrite DI Price

NASDAQ·CLOSED
15.46USD-0.16 (-1.03 %)
Market closed

Over the last 6 years Cellebrite DI grew revenue by 18.5% annually, reaching 475.68 M USD. Earnings per share have grown at 58.8% per year over the last 5 years. For Cellebrite DI, the net margin of 16.5% is down versus 29.0% a few years ago. The consensus 12-month price target for Cellebrite DI is 24.48 USD, about 58.3% above where the stock trades today. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus. The stock trades about 31% above its 52-week low.

Cellebrite DI stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Cellebrite DI over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cellebrite DI stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cellebrite DI's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Cellebrite DI Stock Price History
DateCellebrite DI Price
8/6/202615.46 USD
8/5/202615.62 USD
8/4/202615.58 USD
8/3/202615.07 USD
7/31/202614.75 USD
7/30/202614.57 USD
7/29/202614.70 USD
7/27/202614.81 USD
7/23/202614.06 USD
7/22/202614.18 USD
7/21/202614.75 USD
7/20/202615.37 USD
7/17/202615.44 USD
7/16/202615.83 USD
7/15/202615.83 USD
7/14/202616.18 USD
7/13/202616.45 USD
7/10/202615.94 USD
7/9/202616.13 USD
7/8/202616.42 USD
7/7/202616.57 USD
7/6/202616.14 USD
7/2/202615.65 USD
7/1/202615.45 USD
6/30/202614.60 USD
6/29/202614.01 USD
6/26/202613.76 USD
6/25/202612.63 USD
6/24/202612.69 USD
6/23/202612.74 USD
6/22/202612.42 USD
6/18/202612.83 USD
6/17/202612.47 USD
6/16/202612.81 USD
6/15/202613.05 USD
6/12/202612.84 USD
6/11/202612.84 USD
6/10/202612.99 USD
6/5/202613.81 USD
6/4/202614.29 USD
6/3/202614.18 USD
6/2/202614.98 USD
6/1/202615.87 USD
5/29/202614.73 USD
5/28/202613.20 USD
5/27/202612.70 USD
5/26/202612.89 USD
5/22/202613.18 USD
5/21/202613.17 USD
5/20/202613.40 USD
5/19/202613.46 USD
5/14/202612.89 USD
4/22/202613.30 USD
4/21/202613.25 USD
4/20/202613.38 USD
4/17/202613.18 USD
4/16/202612.71 USD
4/15/202612.51 USD
4/14/202611.86 USD
4/13/202611.80 USD
4/9/202612.41 USD
4/8/202613.43 USD
4/7/202614.15 USD
4/6/202614.10 USD
4/2/202614.00 USD
4/1/202613.88 USD
3/31/202613.78 USD
3/30/202613.23 USD
3/27/202612.95 USD
3/26/202613.79 USD
3/25/202614.16 USD
3/24/202614.21 USD
3/23/202614.84 USD
3/20/202614.27 USD
3/19/202614.84 USD
3/18/202614.58 USD
3/17/202614.69 USD
3/16/202614.40 USD
3/13/202614.44 USD
3/12/202614.53 USD
3/11/202614.49 USD
3/10/202614.70 USD
3/9/202614.93 USD
3/6/202615.30 USD
3/5/202615.19 USD
3/4/202614.16 USD
3/3/202613.75 USD
3/2/202613.50 USD
2/27/202613.34 USD
2/26/202613.76 USD
2/25/202613.72 USD
2/24/202612.63 USD
2/23/202611.94 USD
2/20/202613.16 USD
2/19/202613.78 USD
2/18/202614.04 USD
2/17/202614.30 USD
2/13/202614.64 USD
2/12/202613.70 USD
2/11/202614.26 USD
2/10/202614.94 USD
2/9/202614.65 USD
2/6/202614.17 USD
2/5/202613.59 USD
2/4/202613.95 USD
2/3/202614.28 USD
2/2/202614.90 USD
1/30/202614.71 USD
1/29/202615.29 USD
1/28/202616.01 USD
1/27/202616.59 USD
1/26/202616.56 USD
1/23/202615.87 USD
1/22/202615.82 USD
1/21/202615.74 USD
1/20/202616.38 USD
1/16/202617.00 USD
1/15/202617.41 USD
1/14/202617.55 USD
1/13/202618.00 USD
1/12/202618.05 USD
1/9/202618.46 USD
1/8/202618.35 USD
1/7/202618.78 USD
1/6/202618.40 USD
1/5/202618.06 USD
1/2/202617.84 USD
12/31/202518.03 USD
12/30/202517.99 USD
12/29/202518.24 USD
12/26/202518.41 USD
12/24/202518.74 USD
12/23/202518.88 USD
12/22/202519.24 USD
12/19/202519.21 USD
12/18/202518.70 USD
12/17/202518.38 USD
12/16/202518.23 USD
12/15/202517.85 USD
12/12/202518.82 USD
12/11/202519.06 USD
12/10/202518.50 USD
12/9/202518.39 USD
12/8/202518.10 USD
12/5/202518.28 USD
12/4/202518.20 USD
12/3/202518.00 USD
12/2/202517.81 USD
12/1/202517.14 USD
11/28/202516.86 USD
11/26/202516.83 USD
11/25/202516.80 USD
11/24/202516.88 USD
11/21/202516.88 USD
11/20/202517.44 USD
11/19/202517.66 USD
11/18/202518.30 USD
11/17/202518.17 USD
11/14/202518.45 USD
11/13/202519.28 USD
11/12/202515.97 USD
11/11/202515.70 USD
11/10/202515.61 USD
11/7/202515.40 USD
11/6/202515.26 USD
11/5/202516.05 USD
11/4/202515.90 USD
11/3/202516.62 USD
10/31/202517.06 USD
10/30/202517.17 USD
10/29/202517.39 USD
10/28/202518.49 USD
10/27/202518.50 USD
10/23/202518.42 USD
10/22/202517.78 USD
10/21/202518.50 USD
10/20/202518.05 USD
10/16/202518.11 USD
10/15/202519.30 USD
10/14/202519.45 USD
10/13/202519.56 USD
10/9/202519.05 USD
10/8/202518.99 USD
10/7/202518.49 USD
10/6/202518.80 USD
10/2/202518.77 USD
10/1/202518.50 USD
9/30/202518.53 USD
9/29/202518.97 USD
9/25/202518.30 USD
9/24/202518.46 USD
9/23/202517.85 USD
9/22/202517.97 USD
9/18/202517.87 USD
9/17/202517.26 USD
9/16/202517.26 USD
9/15/202517.43 USD
9/11/202517.18 USD
9/10/202517.10 USD
9/9/202517.27 USD
9/8/202517.09 USD
9/4/202516.37 USD
9/3/202516.51 USD
9/2/202516.36 USD
8/28/202516.71 USD
8/27/202516.47 USD
8/26/202515.80 USD
8/25/202515.83 USD
8/21/202515.91 USD
8/20/202515.48 USD
8/19/202515.80 USD
8/18/202516.16 USD
8/14/202515.29 USD
8/13/202513.99 USD
8/12/202513.91 USD
8/11/202513.52 USD
Access this data via the Eulerpool API
Get Free API Key

Cellebrite DI Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
270.65 M USD
1.04 M USD
120.81 M USD
Jan 1, 2023
325.11 M USD
33.24 M USD
-81.10 M USD
Jan 1, 2024
401.20 M USD
56.91 M USD
-283.01 M USD
Jan 1, 2025
475.68 M USD
66.48 M USD
78.33 M USD
Jan 1, 2026 (e)
567.97 M USD
6.08 M USD
80.17 M USD
Jan 1, 2027 (e)
667.31 M USD
7.14 M USD
107.97 M USD
Jan 1, 2028 (e)
783.15 M USD
8.38 M USD
139.40 M USD
Jan 1, 2029 (e)
864.70 M USD
9.26 M USD
222.47 M USD

Cellebrite DI Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 8, 2026, 10:39 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20192020202120222023202420252026e2027e2028e2029e
171.00194.00246.00270.00325.00401.00475.00567.00667.00783.00864.00
–13.4526.809.7620.3723.3818.4519.3717.6417.3910.34
79.5380.9382.5281.1183.3884.2984.2184.2184.2184.2184.21
136.00157.00203.00219.00271.00338.00400.00477.47561.68659.37727.58
-1.009.0013.001.0033.0056.0066.006.007.008.009.00
-0.584.645.280.3710.1513.9713.891.061.051.021.04
-1.005.0071.00120.00-81.00-283.0078.0080.00107.00139.00222.00
–-600.001,320.0069.01-167.50249.38-127.562.5633.7529.9159.71
122.00187.17199.08192.79194.44247.35251.50251.50251.50251.50251.50
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Cellebrite DI generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cellebrite DI retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cellebrite DI's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Cellebrite DI has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cellebrite DI's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Cellebrite DI stock margins

The Cellebrite DI margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cellebrite DI. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cellebrite DI.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
82.72 %
5.61 %
28.99 %
Jan 1, 2022
81.25 %
0.39 %
44.63 %
Jan 1, 2023
83.63 %
10.22 %
-24.95 %
Jan 1, 2024
84.40 %
14.18 %
-70.54 %
Jan 1, 2025
84.20 %
13.98 %
16.47 %
Jan 1, 2026 (e)
84.20 %
1.07 %
14.12 %
Jan 1, 2027 (e)
84.20 %
1.07 %
16.18 %
Jan 1, 2028 (e)
84.20 %
1.07 %
17.80 %

Cellebrite DI Stock Revenue, EBIT, Earnings per Share

The Cellebrite DI earnings per share therefore indicates how much revenue Cellebrite DI has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
1.24 USD
0.07 USD
0.36 USD
Jan 1, 2022
1.40 USD
0.01 USD
0.63 USD
Jan 1, 2023
1.67 USD
0.17 USD
-0.42 USD
Jan 1, 2024
1.62 USD
0.23 USD
-1.14 USD
Jan 1, 2025
1.89 USD
0.26 USD
0.31 USD
Jan 1, 2026 (e)
2.32 USD
0.02 USD
0.33 USD
Jan 1, 2027 (e)
2.73 USD
0.03 USD
0.44 USD
Jan 1, 2028 (e)
3.20 USD
0.03 USD
0.57 USD

Cellebrite DI business model & stock analysis

Cellebrite DI Ltd is an Israeli company that was founded in 1999 and is headquartered in Petah Tikva. The company specializes in the development and marketing of mobile data extraction and analysis tools, and has gained a reputation as a market leader in the field of forensic data analysis.

Cellebrite DI SWOT Analysis

Strengths

Cellebrite DI Ltd is known for its innovative technology solutions in the field of digital forensics and mobile data extraction. This strength allows the company to stay on top of industry trends and provide cutting-edge solutions to its customers.

With a long history in the industry and a track record of successful partnerships and projects, Cellebrite DI Ltd has built a strong reputation as a reliable and trustworthy provider of digital investigation tools and services. This reputation gives the company a competitive edge in the market.

Cellebrite DI Ltd has a wide international presence, with offices and customers in various countries. This global footprint allows the company to cater to diverse markets and leverage its expertise across different regions, creating growth opportunities and a larger customer base.

Weaknesses

Cellebrite DI Ltd heavily relies on demand from law enforcement agencies for its products and services. Any fluctuations or changes in government budgets or regulations impacting these agencies could potentially affect the company's revenue and growth prospects.

The nature of Cellebrite DI Ltd's products and services requires a high level of technical expertise for their implementation and effective usage. This can pose a challenge for customers who may need to invest in training or hiring specialized personnel to fully utilize the solutions offered by the company.

Opportunities

The digital forensics market is expected to grow rapidly in the coming years due to the increasing need for digital evidence in criminal investigations and legal proceedings. This presents an opportunity for Cellebrite DI Ltd to expand its customer base and revenues by capitalizing on this growing demand.

Cellebrite DI Ltd can explore opportunities to expand its offerings beyond law enforcement agencies and into sectors such as cybersecurity, corporate investigations, and e-discovery. This diversification can open up new revenue streams and increase the company's market presence.

Threats

The digital forensics industry is highly competitive, and Cellebrite DI Ltd faces competition from both established players and emerging start-ups. To maintain its market position, the company needs to continuously innovate and differentiate its offerings from competitors.

Increasing scrutiny and regulations related to privacy and data protection can impact Cellebrite DI Ltd's operations and the use of its technology. Compliance with evolving regulatory frameworks becomes crucial to avoid legal and reputational risks.

Cellebrite DI Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Cellebrite DI Employees
Details
Date
Cellebrite DI Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Cellebrite DI Segments

Cellebrite DI Revenue by Segment (1/2)

  • 3 Years

  • Max

Subscription Services
License and Service
Term-Licenses
Term-license
Professional Services
Perpetual license and related
Other non-recurring
Details
Date
Subscription Services
License and Service
Term-Licenses
Term-license
Professional Services
Perpetual license and related
Other non-recurring
Jan 1, 2021
0.00 USD
183.32 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
153.47 M USD
0.00 USD
0.00 USD
62.49 M USD
33.32 M USD
21.37 M USD
0.00 USD
Jan 1, 2023
209.75 M USD
0.00 USD
70.66 M USD
0.00 USD
31.14 M USD
0.00 USD
13.56 M USD
Jan 1, 2025
330.77 M USD
0.00 USD
96.25 M USD
0.00 USD
30.89 M USD
0.00 USD
17.77 M USD

Cellebrite DI Revenue by Segment (2/2)

  • 3 Years

  • Max

Subscription services
Term-license
Perpetual license and other
Professional services
Details
Date
Subscription services
Term-license
Perpetual license and other
Professional services
Jan 1, 2021
120.89 M USD
62.43 M USD
34.17 M USD
28.76 M USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Cellebrite DI Revenue by Region

  • 3 Years

  • Max

Americas
EMEA
America
Asia Pacific
APAC
Details
Date
Americas
EMEA
America
Asia Pacific
APAC
Jan 1, 2021
0.00 USD
88.44 M USD
126.93 M USD
0.00 USD
30.88 M USD
Jan 1, 2022
0.00 USD
92.75 M USD
141.92 M USD
0.00 USD
35.98 M USD
Jan 1, 2023
172.15 M USD
112.25 M USD
0.00 USD
40.71 M USD
0.00 USD
Jan 1, 2025
256.58 M USD
161.36 M USD
0.00 USD
57.73 M USD
0.00 USD

Cellebrite DI Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Cellebrite DI historical P/E ratio, EBIT multiple, and P/S ratio

Cellebrite DI annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Cellebrite DI shares outstanding

The number of shares of Cellebrite DI was 251.5 M in 2025. This indicates how many shares Cellebrite DI is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
199.08 M Stocks
Jan 1, 2022
192.79 M Stocks
Jan 1, 2023
194.44 M Stocks
Jan 1, 2024
247.35 M Stocks
Jan 1, 2025
251.50 M Stocks
Jan 1, 2026 (e)
251.50 M Stocks
Jan 1, 2027 (e)
251.50 M Stocks
Jan 1, 2028 (e)
251.50 M Stocks

Current Cellebrite DI forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
92.31 % (12)
Hold
7.69 % (1)
Sell
0.00 % (0)
12M Price Target
24.48
Last Price
15.46
Currency
USD
12M Return Potential
58.34 %
LTM Return
0 %

Cellebrite DI Analyst Rating Actions

DateFirmActionRatingReliability
5/15/2026
Needham
Needham
MaintainedBuy70
2/12/2026
Needham
Needham
MaintainedBuy70
11/13/2025
Needham
Needham
MaintainedBuy70
11/13/2025
Lake Street
Lake Street
MaintainedBuy–
11/13/2025
JP Morgan
JP Morgan
MaintainedOverweight80
11/13/2025
B of A Securities
B of A Securities
MaintainedBuy70
9/24/2025
JP Morgan
JP Morgan
MaintainedOverweight80
8/15/2025
Lake Street
Lake Street
MaintainedBuy–
8/14/2025
Needham
Needham
MaintainedBuy70
6/23/2025
JP Morgan
JP Morgan
MaintainedOverweight80

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Cellebrite DI Earnings Calls

2025

Cellebrite DI Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/13/20260.11USD-134.51 MUSD-2026 Q2
5/14/20260.10USD-129.38 MUSD-2026 Q1
2/11/20260.14USD-129.09 MUSD-2025 Q4
8/14/20250.11USD-114.45 MUSD-2025 Q2
11/11/20240.09USD-104.10 MUSD-2024 Q3
11/17/20220.02USD-73.94 MUSD-2022 Q3

Cellebrite DI shareholder structure

% Name
5.66982%
TRUE WIND CAPITAL MANAGEMENT, L.P.
TRUE WIND CAPITAL MANAGEMENT, L.P.
3.95754%
VOSS CAPITAL, LLC
VOSS CAPITAL, LLC
3.47267%
FMR LLC
FMR LLC
2.72535%
PERTENTO PARTNERS LLP
PERTENTO PARTNERS LLP
1.71034%
PHOENIX HOLDINGS LTD.
PHOENIX HOLDINGS LTD.
1.40871%
NINE TEN CAPITAL MANAGEMENT LLC
NINE TEN CAPITAL MANAGEMENT LLC
...

Cellebrite DI Beneficial Ownership Filings (SEC 13D/G)

Free Float
49.5%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
42.67%
SUNCORPORATION
SUNCORPORATION
SEC ↗
17.40%
Moshe Lichtman
Moshe Lichtman
SEC ↗
17.40%
IGP Investments (G.P.), Ltd.
IGP Investments (G.P.), Ltd.
SEC ↗
17.40%
IGP Investments (G.P.L.P), Limited Partnership
IGP Investments (G.P.L.P), Limited Partnership
SEC ↗
17.40%
Haim Shani
Haim Shani
SEC ↗
7.50%
H. Greene Jr.
H. Greene Jr.
SEC ↗
7.50%
H. Clammer
H. Clammer
SEC ↗
7.10%
SPAC Aggregator II, LLC
SPAC Aggregator II, LLC
SEC ↗
6.10%
James H. Greene Jr.
James H. Greene Jr.
SEC ↗
6.10%
Adam H. Clammer
Adam H. Clammer
SEC ↗

Cellebrite DI Executives and Management Board

18 members · avg. age 58 · 28 % women

Management

TH

Mr. Thomas Hogan

Chief Executive Officer, Director · since 2023

–
DB

Mr. David Barter (53)

Chief Financial Officer

–
ZE

Ms. Zohar Tadmor Eilat

Chief People Officer

–
RA

Mr. Ronnen Armon (60)

Chief Products & Technologies Officer

–
SS

Ms. Sigalit Shavit

Chief Information Officer

–
DG

Mr. David Gee

Chief Marketing Officer

–

Board of Directors

AC

Mr. Adam Clammer (54)

Independent Non-Executive Chairman of the Board · since 2025

–
MC

Mr. Michael Capellas (70)

Lead Independent Director

–
NB

Dr. Nadine Baudot-Trajtenberg (68)

Independent Director

–
BB

Mr. Brandon Buren

Independent Director

–
YD

Mr. Yonatan Domnitz (42)

Independent Director

–
DG

Ms. Dafna Gruber (59)

Independent Director

–

Cellebrite DI Supply Chain

Cellebrite DI Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
5 companies
#NameTrend
1
Axon Enterprise
Supplier·Customer·Aerospace & Defense·US
0.25
0.73
0.88
0.83
0.93
—
2
Panasonic Holdings
Supplier·Household Durables·JP
0.10
-0.30
0.10
0.61
0.59
—
3
Cyber Sec 1
Customer·IT Services·SE
-0.06
0.10
0.82
0.50
0.60
—
4
Matrix IT
Supplier·Construction & Engineering·IL
-0.38
0.82
0.80
0.50
0.89
—
5
Suncorp
Supplier·Customer·Technology Hardware, Storage & Peripherals·JP
-0.48
0.18
0.71
0.78
0.88
—

Frequently asked questions about Cellebrite DI

The business model of Cellebrite DI Ltd revolves around digital intelligence solutions and services. Cellebrite DI Ltd specializes in providing a wide range of capabilities to collect, analyze, and interpret data from digital devices. With its advanced technologies, the company helps law enforcement agencies, intelligence organizations, and enterprises to combat digital crime, conduct digital investigations, and enhance cybersecurity. By offering innovative solutions, Cellebrite DI Ltd enables its clients to extract valuable insights and evidence from mobile devices, cloud sources, and social media platforms. Through its comprehensive suite of products, Cellebrite DI Ltd aims to empower its customers with actionable intelligence in the rapidly evolving digital landscape.

Cellebrite DI Ltd is primarily active in the technology and cybersecurity industries.

Cellebrite DI Ltd faces competition from various companies in the market. Some of its main competitors include MSAB, Oxygen Forensics, BlackBag Technologies, and AccessData. These companies also offer digital intelligence and forensic solutions similar to Cellebrite DI Ltd. Nonetheless, Cellebrite DI Ltd distinguishes itself through its cutting-edge technologies and comprehensive range of products and services. With its strong market presence and continuous innovation, Cellebrite DI Ltd remains a leading player in the digital intelligence solutions industry, maintaining a competitive edge over its rivals.

Cellebrite DI Ltd is a renowned telecommunications company with a rich history and extensive background. Established in 1999, Cellebrite DI Ltd has gained recognition as a global leader in digital intelligence solutions. The company specializes in providing advanced mobile data forensics and mobile lifecycle solutions. Over the years, Cellebrite DI Ltd has developed cutting-edge technologies that assist law enforcement agencies, government organizations, and enterprises in analyzing digital data, extracting valuable insights, and solving complex cases. With its innovative software and hardware solutions, Cellebrite DI Ltd empowers its clients to efficiently tackle challenges in the digital world. Through continuous advancements, the company remains at the forefront of the industry, delivering exceptional solutions worldwide.

Cellebrite DI Ltd, a leading digital intelligence company, has achieved significant milestones in its remarkable journey. The company has revolutionized the field of digital forensics and mobile data extraction. Cellebrite DI Ltd has gained recognition for its cutting-edge technology, enabling law enforcement agencies and businesses to unlock crucial evidence from mobile devices. The company has expanded its global presence, catering to customers in over 150 countries. Through continuous innovation and strategic partnerships, Cellebrite DI Ltd has become a trusted name in the industry. Its dedication to excellence and commitment to providing reliable solutions have propelled the company forward, earning it a prominent position in the digital intelligence landscape.

Cellebrite DI Ltd is primarily present in various countries and regions worldwide. These include the United States, Israel (where its headquarters are located), Europe, Asia Pacific, and Latin America.

Cellebrite DI Ltd represents a set of values and a corporate philosophy that drives its operations and services. The company is committed to excellence, innovation, and customer satisfaction. With a focus on providing cutting-edge digital intelligence solutions, Cellebrite DI Ltd aims to empower law enforcement agencies, government entities, and enterprises in tackling complex digital investigations. They strive to uphold the highest standards of integrity, transparency, and accountability in their work. By continually adapting to evolving technologies and delivering efficient solutions, Cellebrite DI Ltd strives to be a trusted leader in the digital intelligence industry.

Analysts currently set an average price target of 25.16 USD for the Cellebrite DI stock (median: 24.48 USD), implying +62.7 % versus the latest price. The consensus is based on 13 analyst ratings.

Cellebrite DI Analyst Price Targets 2026

13 analysts currently rate the Cellebrite DI stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Cellebrite DI to generate revenue of 567.97 M USD and earnings per share of 0.32 USD.

Cellebrite DI Analyst Price Targets 2026

Converted at the current exchange rate, the Cellebrite DI share trades at 13.38 EUR (15.46 USD).

The Cellebrite DI share (CLBT) is listed on 1 stock exchanges, including: NASDAQ (CLBT).

Cellebrite DI is a company specializing in digital forensics and mobile data collection. It offers software-based solutions for mobile forensics, digital forensic labs, mobile data collection, and device unlocking for law enforcement agencies, military and government agencies, as well as businesses and lawyers. The company was founded in Israel in 1999 and is a subsidiary of Sun Corporation, employing over 700 employees worldwide. Cellebrite's products can be divided into three main areas: mobile forensics, digital forensic labs, and mobile data collection and unlocking. They also provide additional services such as training, technical support, and consulting. Overall, Cellebrite DI is a leading company in the field of digital forensics and mobile data collection, aiming to support law and order globally through innovative technologies.

The expected revenue of Cellebrite DI is 567.97 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Cellebrite DI is 80.17 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Cellebrite DI is currently 48.50. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cellebrite DI stock.

The price-to-sales ratio (P/S) of Cellebrite DI is currently 6.85. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cellebrite DI stock.

The Eulerpool Quality Score for Cellebrite DI is 4/10.

The ISIN of Cellebrite DI is IL0011794802. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Cellebrite DI is CLBT. The ticker symbol is used to trade Cellebrite DI shares on the stock exchange.

Cellebrite DI paid dividends every year for the past 0 years.

Cellebrite DI is assigned to the 'Information technology' sector.

The dividends of Cellebrite DI are distributed in USD.

All fundamentals and in-depth analysis of Cellebrite DI

Our stock analysis for Cellebrite DI stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cellebrite DI. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Cellebrite DI Stock
Cellebrite DI Revenue→
Cellebrite DI Stock
Cellebrite DI Net Income→
Cellebrite DI Stock
Cellebrite DI P/E→
Cellebrite DI Stock
Cellebrite DI P/S→
Cellebrite DI Stock
Cellebrite DI EBIT→
Cellebrite DI Stock
Cellebrite DI Dividend→
Cellebrite DI Stock
Cellebrite DI Directors Dealings→
Cellebrite DI Stock
Cellebrite DI Stocks→
Cellebrite DI Stock
Cellebrite DI Market capitalization→
Cellebrite DI Stock
Cellebrite DI Debt→
Cellebrite DI Stock
Cellebrite DI Liabilities→
Cellebrite DI Stock
Cellebrite DI Equity→
Cellebrite DI Stock
Cellebrite DI AAQS→
Cellebrite DI Stock
Cellebrite DI Employees→
Cellebrite DI Stock
Cellebrite DI ROE→
Cellebrite DI Stock
Cellebrite DI ROA→
Cellebrite DI Stock
Cellebrite DI ROCE→
Cellebrite DI Stock
Cellebrite DI News→
Cellebrite DI Stock
Cellebrite DI Analyst Price Targets→

Information technology Stocks

Cellecor GadgetsCeinsys TechCellularline SpACE Info SystemsCELSYSCDWCelxpert EnergyCDS CoCemtrexCCSC Technology International HoldingsCen Link CoCCID Consulting CoAll Stocks A–Z →